![Gérard Soula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 735 444 $ al 30/09/2026
Gérard Soula was the founder of Flamel Technologies SA, founded in 1990, where the title held was Chairman & Chief Executive Officer from 1990 to 2005.
Dr. Soula was the founder of Adocia SA, founded in 2005, where the title held was Chairman, President & Chief Executive Officer from 2012 to 2023.
The current job is Director at Glowbl SAS. Former jobs include Director at Veloxis Pharmaceuticals A and Director at Life Cycle Pharma A. Education includes a doctorate from Université d'Aix-Marseille.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ADOCIA SA 1,29 % | 08/07/2026 | 262.139 ( 1,29 % ) | 735 444 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
GLOWBL SAS
 GLOWBL SAS Packaged SoftwareTechnology Services Designs and develops communications software for videoconferencing and content sharing | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Fundador | 01/01/2005 |
Life Cycle Pharma A/S | Director/Miembro de la Junta | - |
| ADOCIA | Director Ejecutivo | 11/05/2023 |
| VELOXIS PHARMACEUTICALS A/S | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
Life Cycle Pharma A/S | |
Université d'Aix-Marseille
 Université d'Aix-Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GLOWBL SAS
GLOWBL SAS Packaged SoftwareTechnology Services Designs and develops communications software for videoconferencing and content sharing | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
